Pre history (or Before Cyclin)
Cyclins were originally identified (by Tim Hunt on 23rd July 1982) by one-dimensional SDS/ PAGE as proteins in sea urchin eggs that were rapidly synthesized after fertilization [ 13. This discovery had its genesis in studies on translational control, because there was a striking change in the pattern of proteins synthesized before and after fertilization of marine invertebrate eggs [Z] . Most of these proteins, such as the small subunit of ribonucleotide reductase [ 31, simply accumulated through the succeeding cell cycles, but cyclin was remarkable, being destroyed once per cell cycle, at each mitosis. There appeared to be one cyclin in sea urchins, but two in clams, which were designated A and B. Clam cyclin A was the first to be cloned and sequenced, by Swenson et al. [4] , and its connection to the cell cycle was strengthened by their observation that cyclin A mRNA was able to Abbreviations used: APC, anaphase promoting complex; CDK, cyclin-dependent kinase; CAK, CDK-activating kinase; CDI, CDK-inhibitor protein; MAP kinase, mitogen-activated protein kinase; MPF, Mphase promoting factor; PKA, protein kinase A; Rb, retinoblastoma; TGFfl, transforming growth factor fl; UBC, ubiquitin-conjugating enzyme.
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induce meiotic maturation when injected into frog oocytes. This was the classic assay for MPF (originally meiosis promoting factor [S], now referred to as M-phase promoting factor), and it suggested that cyclin could be a component of MPF, or at least involved in the initiation of mitosis. A grand synthesis of cell-cycle studies soon followed, with the discovery that the human homologue of the fission yeast cdc2 kinase and budding yeast CDC28 kinase was able to function in place of the yeast genes [6] and that cdcZ/CDC28 was a component of MPF [7] . Cyclin finally joined cdcZ/CDC28 at the heart of the cell cycle when it was shown to be part of MPF, where it binds and activates cdcZ/CDC28 ~~9 1 .
The age of innocence: when cyclin was cyclin
For a brief moment in cell-cycle studies cyclin took centre stage, when Andrew Murray showed
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that cyclin (sea urchin cyclin B) synthesis and destruction was all that was required to drive a frog egg extract through cycles of both DNA synthesis and mitosis [ 10,111. This emphasizes two fundamental properties of a cyclin: (i) it activates a kinase (in this case cdc2 as part of MPF) to promote a change in the cell cycle; and (ii) the succeeding phase in the cell cycle is triggered by cyclin destruction. Indeed, Murray showed that an N-terminal truncation inhibited cyclin destruction, and this prevented frog egg extracts from exiting mitosis [ l l ] . At this point the cell cycle looked quite straightforward. Cells in interphase synthesized cyclin. When cyclin reached a threshold level it activated cdc2 kinase to cause mitosis. Then cyclin destruction released cells back into interphase, and cyclin synthesis started all over again. Things are not quite so simple now; human cells have at least 14 cyclins with 8 partner kinases [cyclin-dependent kinases (CDKs)] and thus far 7 specific inhibitor proteins. Many cyclins and their partner CDKs play important roles in the regulation of the eukaryotic cell cycle, but the cyclin-CDK motif is also used by the cell to control processes separate from the cell cycle, such as the response to phosphate starvation in yeast, DNA repairhranscription in human cells, and neurofilament phosphorylation in post-mitotic neurons. This may be because the cyclin-CDK motif offers a remarkable degree of flexibility in response to variations in the environment. Such flexibility is conferred by the ability to alter the activity of the cyclin-CDK complex by phosphorylation, or by binding specific inhibitor proteins, or by varying the level of the cyclin itself. T h e rest of this review will try to put some of the cyclins into context, but for more extensive reviews of the cell cycle and of cyclin-CDK regulation see [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] .
The cyclin-CDK motif
In essence cyclins are activators of a family of protein serinehhreonine kinases, the cyclindependent kinases (CDK), which themselves are defined as protein kinases that need to bind to a cyclin to be active [22] . As I have explained, cyclins were originally defined as proteins that were specifically degraded at every mitosis. However, once several cyclin cDNAs had been cloned and sequenced (Figure I ), the definition became that of a protein containing a 100-amino-acid region of similarity to a consensus sequence, the 'cyclin box' [23] . The cyclin box has since been 
Schematic of the cyclin family
Cyclins A to H are grouped according to similarities in their primary structures and thelr roles in the cell cycle G I , G2, CAKjtranscription or unknown Illustrated are the destruction boxes and PEST regions responsible for their destruction The budding yeast Cln (GI cyclins) are also shown Darker hatching indicates regions that are more closely related demonstrated to be involved in binding a CDK [24, 25] . Cyclin nomenclature has carried on the alphabetical classification stemming from the original clam A-and B-type cyclins.
The CDKs also share certain structural similarities (Figure 2) , and are numbered according to the order in which they were shown to bind a cyclin. CDKs are just large enough to encompass all the conserved protein kinase domains [26] , and in domain 111 they all have a sequence related to the canonical EGVPSTAIR-ISLLKE motif found in the first CDKs to be isolated: fission yeast ~3 4 '~' ' and budding yeast p34"')"2x. This region is involved in binding to cyclins (see below) and confers some degree of specificity with which cyclins bind which CDKs (Figure 3 ) . The other region that interacts with the cyclin includes the threonine residue (T-161 in human cdc2, T-160 in CDK2) in domain VIII that is phosphorylated in all active protein kinases. This residue is phosphorylated by a specific protein kinase, CDK-activating kinase Monomeric CDKs are completely inactive as protein kinases; they absolutely depend on binding a cyclin for activation, and now we have a molecular mechanism to explain this depend-
ence. The crystal structures of both an inactive monomeric CDK and an active cyclin-CDK complex have been solved [27, 28] . From a comparison with the active protein kinase A (PKA) structure [29] , two reasons for the inactivity of monomeric CDK2 were immediately apparent. Firstly, ATP was bound in a conformation that would preclude nucleophilic attack on the scissile 1j-v phosphate bond by the substrate hydroxy group. Secondly, part of the C-terminal lobe of the enzyme -the 'T loop' domain -blocked the catalytic cleft. The main reason for the differences in structure between CDK2 and PKA was an a-helical region (stL12) unique to CDK2 that constrained both the ATP-binding site and the T loop domain. Thus cyclin binding was predicted to melt the aL12 helix to allow the ATP-binding site to reconfigure to resemble that of PKA and allow the T loop to move away from the catalytic cleft [27] .
The structure of human CDK2 bound to an N-terminal truncated form of cyclin A has now been solved [28] , and this confirms the predictions of De Bondt et al. [27] . In the cyclin A-CDK2 complex, ATP is bound in the same manner as in PKA and is therefore susceptible to attack from a bound substrate. The T loop 
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domain no longer blocks the catalytic cleft, and the cleft itself has opened up to allow substrates to bind. Cyclin achieves these changes in CDK conformation by binding to the PSTAIRE region and around the T loop, regions previously shown to be important for cyclin binding by mutation and modelling studies [30, 31] . Two cyclin a helices clamp to the middle of the PSTAIRE helix by hydrophobic interactions, and to either end of the PSTAIRE helix by hydrogen bonds. This rotates the PSTAIRE helix -90", moving it into the catalytic site, changes the packing of the Nterminal lobe, and melts the aL12 helix. The reorientation of the PSTAIRE helix brings the side chain of the catalytic residue glutamate-51 into the active site, reconfiguring the way in which ATP is bound such that the fl-y phosphate bond is moved into a position favourable for nucleophilic attack from a bound substrate [28] .
Cyclin also strongly interacts with the Nterminal portion of the T loop, which, because the constraining crL12 helix has melted, moves Volume 24 the T loop away from the active site [28] . Threonine-160 in the T loop is phosphorylated in the fully active kinase, which would probably stabilize the T loop in its new position through ionic interactions with a basic patch of residues in the C-terminal lobe of the protein. T-160 phosphorylation also appears to stabilize the cyclin-CDK complex itself, so there may also be ionic interactions with the cyclin. Furthermore, T-160 in the cyclin-CDK crystal is much more accessible to phosphorylation by CAK, explaining why CAK only phosphorylates CDKs complexed with a cyclin [32] . The crystal structure of the cyclin-CDK complex shows that the region of cyclin involved in binding a CDK is an N-terminal helix followed by a repeat of two sets of five a helices [28] . Each repeat consists of a three-helix bundle with the other two helices packed against the side, and the two sets of a helices can be superimposed on one another. One repeat of a helices is formed by the cyclin box. The second repeat extends from the end of the cyclin box to about 40 amino acids from the C-terminus of the protein, but is only 12% identical to the cyclin box. This repeated structure was noted by Gibson et al., who also pointed out a similar repeat in transcription factor (TF)IIB and the retinoblastoma (Rb) family of proteins [33] , suggesting that this may be a conserved structural motif.
There are five very conserved residues in the cyclin box [24, 34] that have also been shown to be important for CDK binding. Of these, R-211 and D-240 form a buried salt bridge that stabilizes the interaction between the a1 and a2 helices. Two others, K-266 and E-295, hydrogen bond with the PSTAIRE region of CDKZ and with each other. Deletions extending into the helix N-terminal to the cyclin box prevent CDK binding [24, 25] , and in the crystal structure this helix wraps around both cr-helical repeats, stabilizing the R-211-D-240 salt bridge and interacting with the C-terminal lobe of CDK2. The extensive inter-digitation between cyclin A and CDKZ also makes it feasible that cyclins could contribute to the substrate specificity of the cyclin-CDK complex.
T loop phosphorylation
A cyclin-CDK complex is only fully active after the T loop threonine has been phosphorylated by CAK [32] . Furthermore, CAK is itself a cyclin-CDK complex, composed of cyclin H [35, 36] , CDK7 (originally called p40M"" and a Colworth Medal Lecture third protein of -36 kDa [35, 40] . There is potential for CAK activity to be regulated through the synthesis and degradation of cyclin H, but as yet CAK activity has not been found to vary through the cell cycle. Whether one CAK is able to phosphorylate another on the domain VIII threonine, T-176, or whether a different kinase is required, has not been determined, but this is not an auto-phosphorylation event [35, 36] .
CDK7 is almost exclusively nuclear [40] , both cyclin H and CDK7 have consensus nuclear localization signals, and a mutant CDK7 without a nuclear localization signal remains inactive in Xenopus oocytes. Most cyclin-CDK complexes are nuclear, and are therefore probable substrates for CAK. However, the primary mitotic cyclin-CDK complexes, composed of B-type cyclins and cdc2, are cytoplasmic throughout interphase (see below), so there may be a cytoplasmic form of CAK, which may or may not be composed of cyclin H and CDK7.
Cyclin H-CDK7 has also been identified as a component of TFIIH, which contains the RNA polymerase I1 C-terminal domain kinase [41] . It is still unclear whether cyclin H-CDK7 is both CAK and the RNA polymerase I1 kinase, but its role in transcription seems to be conserved through evolution. In budding yeast, the RNA polymerase C-terminal domain kinase has been identified as a cyclin-CDK complex of Ccl and Kin28 [42] , and cyclin H and Ccll are more similar to each other, and to cyclin C, than to any other cyclin.
Regulating cyclin-CDK complexes by phosphorylation . . .
After phosphorylation by CAK, the cyclin-CDK complex can be regulated in two different ways: through phosphorylation or through binding an inhibitor. When bound to a cyclin, the CDK subunit is a substrate for the weel and mikl kinases [43-471. These kinases very specifically phosphorylate a tyrosine (Y-15 in cdc2) in the ATPbinding region of the CDK, which inactivates the kinase by interfering with phosphate transfer to a bound substrate [48] . In animal cells the threonine residue in cdc2 adjacent to Y-15 is also phosphorylated by a membrane-bound kinase activity separate from the tyrosine kinase [49] . Modelling studies suggest that T-14 phosphorylation may inhibit the enzyme in a different manner to Y-15 phosphorylation, by interfering with ATP binding [31] . Inactivation via Y-15 phosphorylation is especially important in the control of the cyclin B-cdc2 complexes in fission yeast and in animal cells. Mutating tyrosine-15 to phenylalanine causes fission yeast to enter prematurely into mitosis [50, 51] , even if the cell has not yet completed DNA replication. This mutation has a slightly less severe phenotype in animal cells, but if threonine-14 is mutated to alanine the double mutation completely deregulates cdc2 activation [52, 53] . In budding yeast, the homologous tyrosine (Y-18) is not important in the regulation of mitosis [54, 55] , but is essential to the proper control of budding [56] . It is less clear whether Y-15 phosphorylation is important in the regulation of other CDKs at other points in the cell cycle, although there are data indicating that CDK4 is tyrosine phosphorylated and inactivated after UV damage [57].
At mitosis, weel/mikl kinase activity is down-regulated by at least two separate kinase activities [58, 59] . One of these kinases is the product of the fission yeast niml gene [58, 60] , and it phosphorylates residues in the C-terminus of weel. Another as yet unidentified kinase(s) phosphorylates the N-terminus of weel [59] .
. . . and dephosphorylation
Threonine-14 and tyrosine-15 are dephosphorylated by a specific family of phosphatases. First identified as the product of the cdc25 gene in fission yeast [61] , at least three Cdc25 family members (A, B and C) have been isolated from animal cells [62] . The Cdc25 phosphatases are dual-specificity phosphatases whose closest relatives are the protein tyrosine phosphatases of Vaccinia virus and of the plague pathogen, Yersinia pestis, and are highly specific for phosphorylated T-14 and Y-15 in CDKs [63-671. In animal cells, Cdc25A is phosphorylated and activated by cyclin E-CDK2 at the initiation of DNA synthesis [68, 69] . It is not clear whether Cdc25A in turn activates more cyclin E-CDK2 in a positve feedback loop, although this seems likely. There are also reports that Cdc25A interacts with Rafl, and that both Cdc25A and Cdc25B are able to co-operate with Ras in cell transformation [70] . The point of action of Cdc25B in the cell cycle is not yet known.
At mitosis, Cdc25C activates cyclin B-cdc2 complexes, after cdc25 is itself activated by phosphorylation. Cdc25 is a cyclin B-cdc2 substrate, so the phosphatase and kinase form a positive feedback loop that ensures rapid activation of a pool of cyclin B-cdc2 at mitosis [71] (reviewed in [72] ). However, the identity of the kinase that initially activates Cdc25 at the beginning of mitosis is not known. Cdc25C is recognized by the MPM-2 monoclonal antibody [73] , which recognizes a mitotic phosphorylation epitope [74] . Therefore Cdc25C may be activated by one of the two partially characterized MPM-2 kinases, neither of which is a cyclin-CDK kinase [75] .
The weaker kinase appears to belong to the mitogen-activated protein (MAP) kinase family, which ties in with the regulation of the metaphase-anaphase checkpoint by MAP kinase.
CDK inhibitors
The most topical means of regulating cyclin-CDK activity is through the CDK-inhibitor proteins (CDI or CKI). An in-depth review of the CDIs is beyond the scope of this lecture, so for a more detailed treatment see [76, 77] .
CDIs are usually small (15-27 kDa) proteins that bind and inactivate specific cyclin-CDK complexes, or in some cases monomeric CDKs. All of the inhibitors isolated from animal cells appear to be primarily concerned with signal transduction and the decision to senesce, quiesce or differentiate. In contrast, the rum1 and SIC1 inhibitors in fission and budding yeast, respectively, are concerned with the proper coordination of DNA replication and mitosis. No doubt homologues of these yeast proteins will soon be identified in multicellular organisms. One candidate protein is Roughex in Drosophila cells, which is required to establish a G1 phase as well as being required to prevent an extra M phase after meiosis I1 [78, 79] .
Mammalian CDK inhibitors
Two families of CDK inhibitors have been isolated from animal cells so far. The members of the Ink4 family, p16'"K4a [80] , ~1 5 ' " "~~ [81] , ~1 8 ' "~~" [82, 83] and p19"K4d [83] , are each composed of four ankyrin repeats and are closely related in sequence. The genes encoding p16 and p15 are adjacent on the 9p12 locus [84] . Members of this family only bind CDK4 and CDK6 and appear to compete for binding with the D-type cyclins. p16 is a potential tumour suppressor gene; it is rearranged, deleted or mutated in a large number of tumour cell lines, and in some primary tumours [84, 851 , and p16 is able to counteract Ras-induced cell transformation [86] . T o some extent it appears that the loss or mutation of either p16 or Rb has a similar effect in deregulating the D-type cyclins. p15 appears to be on one pathway through which some cells arrest in response to transforming growth factor B (TGFB). For example p15 mFWA and protein levels are induced more that 30-fold when HaCaT cells are exposed to TGFB [81] . Like p16, p18 appears to require Rb to arrest the cell cycle [82] , whereas p19 does not. The levels of p19 appear to vary during the cell cycle, peaking as cells enter S phase [83] .
The second family of inhibitors comprises P21 ("P'MIAFI, ~2 7~" ' and p57K'pZ [77] . ~2 7~' " is another effector of cell-cycle arrest in response to TGFB, and seems to be present in proliferating cells in a latent or masked form [87, 88] . Several stimuli in addition to TGFB are able to unmask p27, including cell-cell contact [87] and cyclic AMP treatment of macrophages [89] . Once unmasked, p27 binds and inhibits the cyclin E-CDK2 complex, although in proliferating cells most p27 is bound to cyclin D-CDK4/6 complexes [90] . p27 may inhibit cyclin D-CDK4 through preventing the phosphorylation of the T loop threonine residue in CDK4 (T-172) by CAK [89] . Increasing the amount of p27 (cyclic AMP treatment of macrophages) or decreasing the amount of CDK4 (TGFB treatment) would both block cells in G1 phase [77] . Conversely, in Tlymphocytes, interleukin 2 treatment depresses p27 levels, while antigen stimulation increases cyclin D2 and D3 synthesis, causing T-cells to proliferate [91] . p27 is closely related to p57 in its N-and C-terminal sequences, but p57 has in addition one large proline-rich and one acidicrich domain in the middle of the protein. Hybridization in situ shows that both p27 and p57 are most abundant in post-mitotic, differentiated tissues, such as muscle and brain, although p57 is more restricted in its distribution [92, 93] . p57 also maps to llp15, a chromosomal locus that is re-arranged in many tumours [93] . Like ~2 7~" " , p57K'1'2 is able to inhibit cyclin D-, cyclin E-and cyclin A-associated kinases, and does not require Rb or wild-type p53 to induce G 1 arrest when transfected into tissue-culture cells.
T h e N-termini of p27 and p57 have strong similarity to that of p21 [87, 90] . p21 forms a ternary complex with PCNA (a subunit of DNA polymerase 6) in several cyclin-CDK2 complexes, including cyclins A, D1 and E, and p21 also binds, more weakly, to CDKl and CDK3 [94-961. The exact mechanism by which p21 inhibits cyclin-CDK kinase activity is not clear. Unlike p27, it does not appear to affect the phosphorylation state of the CDK, and more than one p21 molecule needs to bind to a cyclin-CDK The C-terminus of p21 has been shown to be complex in order to inhibit protein kinase activity responsible for inhibiting PCNA in vztro [97] . An analysis of p21 mRNA in growing, qui- [104, 105] , but it remains to be seen whether p21 escent and senescent cells correlates with a role ever acts through inhibiting PCNA in vivo. On as a negative regulator of entry into S phase. p21 mRNA is up-regulated as cells become senescent or quiescent, and after serum stimulation of quiescent cells, and decreases as cells enter S phase Overexpressing p21 suppresses growth in various human tumour cell lines, and inhibits DNA synthesis in non-transformed cells [94] . The negative effect of p21 on DNA replication in normal cells can be overcome by overexpressing SV40 T antigen, and in T antigen-transformed cells p21 is absent from cyclin-CDK complexes [96] . The p53-dependent G1-phase arrest in response to UV damage appears to be effected through p21. p21 is induced by wild-type, but not mutant, p53 [99] , and cells irradiated in G1 phase require wild-type p53 in order to arrest the cell cycle before S phase [loo], although there is some controversy over whether cells arrest transiently, or indefinitely in a state resembling senescence [loll.
In an SV40 T antigen-dependent replication system in zlitro, p21 is able to inhibit DNA replication without the mediation of cyclin-CDK complexes, by binding to PCNA [102] . Furthermore, DNA excision repair, which requires PCNA, is not sensitive to p21 inhibition [103] .
[981.
the one hand, in Xenopus egg extracts, exogenous p21 inhibits DNA replication exclusively through inhibiting cyclin-CDKs [ 104, 105] , such that replication can be restored by the addition of cyclin E or cyclin A kinase [lob] . On the other hand, tissue-culture cells are arrested when transfected with either the amino or the carboxyl half of p21 [lo71 ( Figure 4) .
As yet a specific inhibitor for the cyclin 0-cdc2 complex has not been identified, although p21 will weakly inhibit this kinase [94, 95] . One indication that there is an inhibitor for the mitotic form of cdc2 is that purified frog MPF (essentially, but not exclusively, cyclin B-cdc2) is inactivated when added to an interphase extract in a manner independent of T-14B-15 phosphorylation of cdc2 [108] .
Thus we have some understanding of how cyclins activate their partner CDKs, and of how the cyclin-CDK complex can be further modulated by phosphorylation and by binding inhibitors. Progress is also being made in dissecting the other defining feature of a cyclin, its rapid cell-cycle-dependent destruction. Indeed, the cell-cycle-dependent destruction of specific proteins, including both CDK activators (cyclins) and inhibitors, is one of the most conserved 
Cyclin destruction
Cyclins can be divided into the same two classes according to where they act in the cell cycle (G1 or G2 phase) or to the character of their destruction. The G1 cyclins (D and E) are constitutively unstable through the cell cycle, and their level is therefore determined by the rate of their transcription. By contrast, the G2 cyclins (A and B) are unstable in only one phase of the cell cycle, mitosis.
Cyclin proteolysis: 'destruction boxes' and ubiquitin
The original cyclins, A and B, are stable throughout interphase and are specifically destroyed at mitosis. This property is conferred by a partially conserved destruction box in the N-terminus of the protein [109] . The destruction box almost certainly marks cyclins for degradation at mitosis through ubiquitination [ 109,1101. On its own the destruction box is not necessarily sufficent to mark the cyclin for destruction, because both cyclin A and cyclin B2, and in some circumstances, cyclin B1, need to be able to bind to their CDK partner in order to be degraded [34, 111] .
T h e ubiquitin degradation pathway involves up to three enzyme components to charge and transfer the ubiquitin moiety (reviewed in [ 1121) ( Figure 5 ). Ubiquitin is transferred to the substrate protein either by a ubiquitin-conjugating enzyme (UBC) alone or by a UBC in conjunction with a ubiquitin ligase. Cyclins are recognized by particular UBCs in yeast, and a potential cyclinspecific UBC has been isolated from clam oocytes [ 1131. How specific any one UBC is for a particular motif is unknown. There could be a cyclin A-specific and a cyclin B-specific UBC, because the sequence of the destruction box varies between the A-and B-type cyclins, and the A-type cyclins begin to be destroyed in metaphase, whereas the B-types are destroyed when cells enter anaphase [ 114-1 181. In budding yeast the degradation of the S-phase-specific Clb5, perhaps analogous to cyclin A, and the mitosisspecific Clb2 cyclin, analogous to cyclin B, both require the product of the UBC9 gene [119] . However, in a reconstituted system using Xenopus components, the frog UBC9 homologue did not cofractionate with the E2 responsible for cyclin destruction. A homologue of yeast UBC4 did cofractionate, and bacterially expressed human UBC4 was able to ubiquitinate sea urchin cyclin B with the other components of the reconstituted system.
T h e other major component involved in the The control of cyclin destruction by ubiquitination [121] . The human CDC16 and CDC27 proteins have been shown to associate with the spindle and the centrosome [ 1201, which is almost certainly connected with the observation that B-type cyclin destruction is sensitive to the integrity of the mitotic apparatus at the end of metaphase. If the spindle is incorrectly assembled, or chromosomes are incorrectly aligned, then B-type cyclin destruction is inhibited. The MAP kinase ERK2 is part of the mechanism that prevents cyclin B1 destruction when the cell arrests at metaphase in adverse conditions [ 1231. Spindle integrity is assayed through the tension on the microtubules created by the attachment of kinetochores to microtubules [124, 125] . Ubiquitinated proteins are degraded by the 2 6 s protease, which is made up of a core 2 0 s proteosome particle and various ATPase subunits. A yeast with a mutation in one of the ATPase subunits is known to arrest cells in mitosis through an inability to degrade B-type cyclins, because the mutation can be suppressed by a mutation in the B-type cyclin encoded by CLB2 [126, 127] .
Other proteins are also specifically degraded in mitosis. Some, such as the unidentified components that link sister chromatids together [127a] , are degraded at the same time as the cyclins, and their degradation can be competitively inhibited by a cyclin substrate. Others, such as CENP-E [128] , are degraded later in mitosis, suggesting that there are specific waves of protein destruction as cells move through mitosis.
In yeast the B-type cyclins remain unstable through G1 phase until G1 cyclin-CDK (ClnCdc28) activity appears at START [129] , suggesting that the G1 cyclin-CDK protein kinases turn off B-type cyclin destruction. There are indications that this holds true in the animal cell cycle too. Ectopic expression of the G1 cyclin, cyclin E, in Drosophila is sufficent to cause postmitotic G1 cells to undergo another round of DNA replication and cell division [130] . In these cells, ectopic cyclin E was sufficent to stimulate the accumulation of the mitotic cyclins A and B with no increase in their mRNA levels, suggesting that cyclin E stabilizes cyclin A and B by shutting off the proteolytic machinery [ 1301.
G I cyclin proteolysis: PEST sequences and ubiquitin
The human D-and E-type cyclins are short-lived proteins, as are the Cln proteins in budding yeast. The short half-life ( -20 min) is due to PEST sequences in the C-terminal regions of the proteins; removing the PEST sequences stabilizes the proteins [ 13 1 -1331. There is some debate over whether PEST regions confer instability directly or not, and the biochemical basis for the degradation of proteins containing PEST regions has not yet been elucidated. However, recent evidence shows that yeast G1 cyclin destruction, like that of the G2 cyclins, is mediated by ubiquitin [ 1341.
In yeast the cyclin-dependent kinase inhibitors Sicl and Farl are destroyed once cells pass START, the point in G1 phase when cells are committed to the mitotic cell cycle. Farl inhibits the G1 cyclin-CDK complex (Cln2-Cdc28) [135- 1371 in response to activation of the MAP kinase pathway, and may therefore be the paradigm for p21 and p27. Sicl inhibits the S-phase cyclin-CDK complex (Clb5-Cdc28) [ 1381 to prevent cells from entering prematurely into S phase, and is therefore involved in co-ordinating the cell cycle proper. Sicl is recognized by the UBC product of the CDC34 gene, and there are indications that both Sicl and Farl are only degraded in their phosphorylated form.
Thus cell-cycle control appears at heart to be due to the sequential destruction of different sets of cell-cycle regulators at specific phases of the cell cycle [129] . Sequential waves of proteolysis could in part be achieved by activating the ubiquitin-conjugating machinery only at particular points in the cell cycle, perhaps through phosphorylation by cyclin-CDK kinases.
The importance of transcription (but you won't find the details here)
In addition, there is a complex interplay between the transcription machinery and the cyclinCDKs. This has been most clearly defined in budding yeast, where G1 cyclin complexes form a positive feedback loop with the SBF (Swi4/Swi6 cell cycle box factor) and MBF (MluI cell cycle box factor) transcription factors to regulate G1-phase and S-phase entry. Later in the cell cycle, the G2 cyclins (Clbs) activate their own transcription and turn off G1 cyclin transcription ( [139] ; reviewed in [16] ). The interplay between transcription factors and the cell-cycle machinery in human cells is equally important, but much less exactly defined. T h e E2F family of transcription factors has been strongly implicated in controlling the induction of S phase (see below), but the interplay between these factors and cyclin-CDK complexes is much less clear. Later in the cell cycle, the transcription of G2-phase components such as Cdc25C and cdc2 appears to be under the control of a repressor that binds to a specific repressor element [ 1401.
Thus the waves of cyclin-CDK activity that appear sequentially through the cell cycle ( Figure 6 ) are due in part to proteolysis and in part to transcription.
G I cyclins
So, how do the plethora of cyclins, CDKs and CDK inhibitors act to regulate the human cell cycle? Different cyclin-CDK complexes have essential roles in the transition from one cellcycle state to another, most importantly the initiation of DNA replication or cell division, and also in the integration of cell progression with other cell fates such as differentiation, senescence and quiescence.
The D-type cyclins ( [141] ; reviewed in [ 1421) are most closely connected with a control point in mid-late G1 phase called the Restriction point (R) [143] , which is the point at which cells respond to the presence of serum by commitment to the mitotic cell cycle, or to the absence of serum by becoming quiescent. This is also probably the point at which cells exit the cell cycle when they differentiate or become senescent. The D-type cyclins are especially suited to a role in signal transduction, because their transcription is serum dependent. In the absence of serum, their short half-life means that the Dtype cyclins rapidly disappear.
There are three D-type cyclins in mammalian cells, which are cell-type specific [141] . Cyclin D1 is the Bcl-l/PRADl proto-oncogene Colworth Medal Lecture product [ 144,1451, and the overproduction of cyclin D1 through gene amplification or mRNA stabilization has been correlated with several types of cancer (reviewed in [76, 146, 147] ). The exact role of the D-type cyclins in the proliferating cell cycle is not clear, but cyclin D1 only appears to perform an essential function in cells that have a functional Rb protein [148] . D-type cyclins bind to several different CDKs, CDK2, CDK4, CDK5 and CDK6 [149-1521, of which the main partners appear to be CDK4 [149] and CDK6 [151, 152] ; in many cell types CDK2, CDK5 and CDK6 are not associated with cyclin D [151] . The cyclin D-CDK4 complex is unusual because it forms for only a short period in the cell cycle, at R through to early S phase [149] , even though cyclin D and CDK4 remain at almost constant levels in cycling cells. Thus part of the control of R is through regulating the association between cyclin D and CDK4, for example through the effect of p27 on the phosphorylation of the T loop threonine in CDK4. CDK4 synthesis itself is also subject to regulation by negative growth factors such as TGFP [153] .
Cyclin D-CDK4 complexes have a restricted substrate specificity. These include the E2F family of transcription factors [ 1541, thought to regulate the cell-cycle-dependent synthesis of proteins required for S phase, such as DNA polymerase a, thymidylate synthetase and ribonucleotide reductase, as well as cyclins E and A (reviewed in [155, 156] ). E2F is a dimer composed of a member of the E2F family [157, 158] (five different cDNAs have been isolated) and a member of the DP family [159, 160] (of which three cDNAs have been found so far).
T h e second substrate identified for the Dtype cyclin-CDK complexes is Rb [161] . Rb is under-phosphorylated in most of G1 phase, phosphorylated at or after R, and remains phosphorylated until late mitosis [162, 163] . The hypophosphorylated form of Rb is able to block cells in G1 phase, and it binds, and potentially sequesters, a large number of proteins, including E2F. T h e D-type cyclin-CDK complexes may phosphorylate and inactivate Rb in mid-late G1 phase. In vztro, the D-type cyclins are able to bind to Rb through an L-X-C-X-E motif in their N-terminus [ 164-1661.
T h e role of Rb itself in the cell cycle is contentious. An Rb-mouse undergoes multiple normal rounds of cell division and considerable tissue differentiation until day 13, at which point it dies because of problems in the development of the liver and blood system [167-1691. This suggests that Rb is only important for a subset of cell differentiation, notably haematopoeisis and neurogenesis, rather than regulating the cell cycle. Rb probably acts to arrest the cell cycle at R, by sequestering or inactivating transcription factors such as E2F that are involved in the synthesis of genes required for DNA replication.
Differentiation and transformation
The D-type cyclins and Rb are important in the switch between proliferation and differentiation, and there are also some data to suggest that CDK4 needs to be down-regulated in order to allow differentiation [ 165,1701. In the 32D myeloid cell line cyclins D2 and D3 are normally expressed in a growth-factor-dependent manner [171] . However, if the cells are transfected with either cyclin D2 or D3 under a constitutive promoter, cells are unable to differentiate. The constitutive expression of cyclin D1 has no effect on their differentiation, nor does expression of cyclin D2 and D3 mutants that are unable to bind Rb [171] . In an analogous fashion, ectopic cyclin D1 inhibits the differentiation of the C2C 12 myoblast cell line, apparently through inhibition of MyoD [172] , and this can be overcome by ectopic p21. p21 and MyoD could form a positive feedback loop in muscle differentiation, because p21 is induced by MyoD. Thus, as muscle cells begin to differentiate, MyoD could increase p21 levels, inhibiting cyclin Dl-associated kinase activity, and allowing MyoD to increase transcription of p21 as well as musclespecific genes [172-1741. However, MyoD is not solely responsible for the induction of p21, because myoblasts are able to induce p21 synthesis and differentiate in mice lacking both MyoD and myogenin [ 173, 1741 . A correlation between p21 transcription and differentiation has also been observed in other cell types, such as cartilage and epithelium [174] .
These observations may provide an explanation for the ability of D-type cyclins to act as proto-oncoproteins; if their deregulation signalled the cell to proliferate rather than differentiate, then this is one of the conditions necessary for cellular transformation [ 1751. Cyclin D expression would therefore be expected to cooperate with other oncoproteins in cellular transformation, and indeed cyclin D 1 will co-operate with Myc in transgenic mice [176] , and withRas and a defective E1A protein in cultured cells
[ 1771. For a comprehensive review of the connections between cyclins and oncogenesis see [ 76,1781. In proliferating cells, CDK5 is bound to the D-type cyclins but has little detectable kinase activity. However, in post-mitotic neurons, CDK5 takes on the role of a neurofilament kinase [179] . Interestingly, its partner is p35, a protein with very limited homology to cyclins [180, 181] . It will be interesting to solve the crystal structure of CDK5, and of the p35-CDK5 complex, to determine whether p35 activates CDK5 in the same way as a cyclin.
Cyclin E and the G I to S transition
The other G1 cyclin that has been identified in human cells is cyclin E. Overproducing either Dtype cyclins or cyclin E moderately shortens G1 phase in mammalian cells [ 182-1841, whereas overproducing both D-and E-type cyclins significantly shortens G1 phase [185] . This suggests that the two types of cyclin regulate different aspects of G1 phase.
The cyclin E-CDK2 complex appears after the D-types [186, 187] , such that there is a burst of cyclin E transcription only in late G1 and early S phase. Additionally, cyclin E-CDK2 protein kinase activity may be modulated by Cdc25A phosphatase at the end of G1 phase [69] . The cyclin E-CDK2 complex is essential for the cell to begin DNA replication. The best evidence for this comes from studies on developing Drosophila embryos. In Drosophila embryogenesis, the disappearance of cyclin E transcripts after mitosis 16 causes cells to stop dividing and arrest in G1 [ 1301. Some cells go on to complete endoreplication (DNA synthesis without cell division) after cycle 16, and the presence of cyclin E transcripts correlates exactly with cells that are capable of endoreplication [ 130, 1881 . Furthermore, cells of a Drosophila mutant in cyclin E are unable to enter S phase after the maternal store of cyclin E has been exhausted.
A homologue of the mammalian E2F transcription factor has been isolated from Drosophila, and one of its target genes is cyclin E [189, 190] . Moreover, ectopically expressed cyclin E is able to overcome the cell-cycle arrest caused by a defective E2F gene [189] . Thus it appears that cyclin E is one of the major limiting downstream targets of E2F in the initiation of S phase. Conversely, E2F is unable to rescue a defect in cyclin E, so cyclin E-associated kinase activity must be required for more that just the activation of E2F
[ 1891. The relationship between E2F and cyclin E looks to be conserved in evolution because mammalian cyclin E (and cyclin A) synthesis is strongly stimulated by ectopic E2F-1 [191] .
Further evidence for a requirement for cyclin E-CDK2 to initiate S phase is that in Xenopus egg extracts almost all the CDK2 is bound to cyclin E, and DNA synthesis is blocked when CDK2 is depleted [192] . Similarly a dominant negative form of CDK2 will inhibit the initiation of DNA replication in mammalian cells, blocking cells in G1 phase, at which point CDK2 is primarily bound to cyclin E [193] .
Cyclin A, the M&S cyclin
Once cells have entered S phase, the predominant cyclin-CDK complex that is active through to the end of G2 phase is cyclin A-CDK2 . Cyclin F is also active at this point, and, although its substrates have not been identified, anti-sense data suggest that cyclin F is required for entry into M phase [197] . A continuing debate over cyclin A is whether it has a role in initiating S phase, or whether it only maintains DNA synthesis once S phase has been initiated by cyclin E. If cyclin A is artificially produced in G1 phase, this has the effect of advancing S phase [198] . However, the cyclin A promoter normally begins to be transcribed only in late G1 or the beginning of S phase, so whether there is normally enough cyclin A in late G1 to contribute to the initiation of DNA replication is unclear.
S-phase substrates for cyclin A have been reported to include E2F-1, which is apparently unable to bind DNA after phosphorylation [199, 200] . Thus a model has been proposed by which cyclin E activates E2F-1, and thus initiates the transcription of genes required for DNA synthesis in late G1 phase, and cyclin A turns E2F off once cells are in S phase. Cyclins A and E also bind to the Rb-related proteins p107 and p130 [201, 202] , and recent data suggest that this interaction may be the means by which another member of the E2F family, E2F-4, is regulated [203] . In G1 phase a minor proportion of E2F-4 [204, 205] and p107 is found in a complex with cyclin E-CDK2, and in S phase a larger proportion of E2F-4 and p107 associates with cyclin A-CDK2 [201, 206, 207] . Activated cyclin A-CDK2 causes p107 to dissociate from E2F-4, but p107 appears to be able to inhibit cyclin A-CDK2 activity in an analogous fashion to p21 or p27; furthermore, these three proteins share a small region of similarity and bind to cyclin-CDKs in a mutually exclusive fashion [203] . Thus it has been proposed that p107 may function as an inhibitor of cyclin-CDK activity as well as to target cyclin-CDK complexes to E2F [203] .
The role, if any, of cyclin A in DNA replication itself is also contentious. Cyclin A co-localizes with origins of replication [208, 209] , and cyclin A-CDK, as well as cyclin E-CDK2, complexes are able to rescue DNA replication in cellfree extracts from Xenopus eggs that have been inhibited by ~21"'"' [ 1061. However, neither Drosophila embryos nor an in vitro SV40 T-antigen-dependent system need cyclin A to replicate DNA [210-2121. In the latter case, this indicates that if cyclin A-associated kinase activity is required, then it is only needed for origin unwindinglinitiation and not elongation.
The G2 phase substrates of cyclin A-CDK2, and of cyclin A-cdc2, which forms later in G2 phase, also remain obscure. It is clear from an analysis of Drosophila embryos mutant in cyclin A that this cyclin plays an essential role in the initiation of mitosis. Once embryos have exhausted their supply of maternal cyclin A, all the cells arrest in G2 phase, having completed DNA replication [211] . Cyclin A-CDK complexes may be involved in the initiation of spindle assembly, because in Xenopus cell-free extracts cyclin A-CDK kinase activity causes centrosomes to nucleate arrays of microtubules [213, 214] .
Cyclin B: the mitotic cyclin
The cyclin with the clearest cell-cycle role is the 'original cyclin', cyclin B. Cyclin B, in partnership with cdc2, is the primary mitotic kinase, and a large number of mitotic substrates have been proposed for it (reviewed in [215] ). These include both downstream mitotic kinases such as NIMA [216, 217] and karyoskeletal and cytoskeletal elements such as the nuclear lamins [218] , actin-binding proteins [219, 220] , and microtubule-associated proteins [221] . Thus cyclin B-cdc2 is both a regulator and a 'workhorse' of mitosis [215] . As outlined above, the activation of cyclin B-cdc2 is very carefully regulated by phosphorylation and dephosphorylation of cdc2, through the weel/mikl kinases and Cdc25C phosphatase. In addition, some of the cyclin B-cdc2 complexes undergo cell-cycledependent translocation to the nucleus [ 116, 222, 2231 , and my own research has focused on this aspect of the cyclins.
Localization
A third feature of the cyclins, along with their activation of CDKs and cell-cycle-dependent destruction, is that cyclins appear to target their partner kinases to particular sub-cellular compartments and substrates. Localization may be one way in which the cyclins can confer substrate specificity on their partner kinase. For example, the nuclear cyclins A and E bind to p107 [201] and p130 [202] , and this means that cyclin A-CDK2 phosphorylates p107 much more efficently than does cyclin B-cdc2 [224] . Also, the NAP1 protein interacts specifically with mitotic B-type cyclins in yeast and frogs, and is required for the proper regulation of mitosis [225, 226] . Localization is likely to be especially important for the mitotic cyclin-CDK complexes that have almost identical substrate specificities in vitro [215] . My recent research has concentrated on the A-and B-type cyclins to define their locations in the cell, and to determine which parts of the molecule are responsible for their localization.
Cyclins are mostly nuclear proteins, with the exception of the metazoan B 1, B2 [ 116, 222, 2231 and Drosophila A-type cyclins [210] . Mammalian cyclin B 1 [ 1161 and avian cyclin B2 [222] accumulate in the cytoplasm in G2 phase and translocate into the nucleus at the beginning of mitosis. Similarly, in starfish oocytes the B-type cyclin translocates into the germinal vesicle when the oocytes are fertilized or activated [223] . Subsequently, cyclin B associates with the spindle apparatus, in particular with the spindle caps [ 116, 222, 2231 , and this is congruent with the behaviour of fission yeast cyclin B (cdcl3), which associates with the spindle poles [227] . The association of cyclin B with the spindle has at least two implications. Firstly, it means that cyclin B-cdc2 kinase may be involved in the formation of the spindle through phosphorylating components of the mitotic apparatus. Secondly, it would facilitate the feedback mechanism that links cyclin B1 destruction to the correct assembly of the metaphase mitotic apparatus.
Human cyclin B2-cdc2 has an identical substrate specificity in vitro to cyclin B1-cdc2, and its associated protein kinase activity is turned on and off at the same time in the cell cycle. However, cyclin B2 differs strikingly from cyclin B1 in its localization in human cells, in that it is almost exclusively associated with the membrane compartment, and in particular the Golgi apparatus [228] . This immediately suggests that cyclin B2-cdc2 is involved in the disassembly of the Golgi apparatus when cells enter mitosis [229] . At mitosis membrane traffic is inhibited, and data from systems in vitro have shown that cdcZassociated protein kinase activity is able to inhibit membrane fusion [230, 23 11.
B-type cyclins are targeted to the cytoplasm
T h e 'default' localization of a cyclin-CDK complex is the nucleus. Through a series of deletion mutants and domain swaps, I have shown that the cyclin box alone is nuclear [232] , and Erich Nigg and colleagues have shown that, in order to be transported to the nucleus, the cyclin needs to bind to its CDK [233] . The cytoplasmic localization of the B1 and B2 cyclins is determined by a -42-amino-acid region in the N-terminus between the destruction box and the cyclin box [232] . This region appears to act as a cytoplasmic anchor, because it is able to re-direct cyclin A to the cytoplasm when fused to the Nterminus. The cytoplasmic anchor region of cyclins B1 and B2 is partially conserved, and is both necessary and sufficent to direct cyclin B1 to microtubules and cyclin B2 to the membrane compartment of the cell. Ookata et al. [221] have shown that one of the proteins that interacts with cyclin B1 on microtubules is MAP4, and cyclin B1 is able to phosphorylate MAP4, which appears to increase the dynamic instability of microtubules in vitro. This is the behaviour of microtubules in mitosis and has also been shown to occur when cyclin B1 kinase is added to Xenopus extracts, where in addition it was shown to depress microtubule nucleation on centrosomes [213, 214] .
Future studies: cyclins in real time
Mitosis is the most dynamic part of the cell cycle; most of the cellular architecture is reorganized and new structures such as the spindle are formed. Some of the cyclin-CDK complexes, such as cyclin B 1 -cdc2, are themselves dynamic in mitosis, translocating from the cytoplasm to the nucleus and associating with the spindle. Thus one of our aims is to be able to observe cyclins in living cells. T o this end I have created fusion proteins between the cyclins and the naturally fluorescent 26 kDa Green Fluorescent Protein of the jellyfish Aequoriu victoria [234] . Our studies have only just begun, but we have been able to detect cyclin fusion proteins, and have shown that they are localized to the same compartments as the endogenous cyclins [235] . Thus we hope to be able to unlock some of the secrets of cell-cycle regulation by observing cyclins throughout the cell cycle in living cells. Just one more transition in the short but eventful life of the cyclins: from a band on a gel, to a consensus protein sequence, to a crystal structure, and now, I hope, to a green light for cell-cycle research! This lecture is dedicated to Dr. Tim Hunt, who introduced me to cyclin and the cell cycle, and not least to John Elliot Gardner in a Metro over the Alps. True inspiration.
